基本信息
views: 245
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
His work focused on the development of monoclonal antibody-based strategies for the treatment of melanoma and epithelial cancers. Alongside J. Mendelsohn, he led the fi rst clinical trial with anti-EGFR monoclonal antibodies in humans.
Research Interests
Papers共 581 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF PATHOLOGYno. 4-5 (2024): 397-399
Sergi Cervilla,Daniela Grases, Elena Perez,Francisco X. Real,Eva Musulen,Manel Esteller,Eduard Porta-Pardo
crossref(2024)
biorxiv(2024)
Cell Reports Medicineno. 5 (2024): 101557-101557
Cristina Bodas, Irene Felipe, Brice Chanez,Miguel Lafarga, Evangelina López de Maturana, Jaime Martínez-de-Villarreal,Natalia del Pozo,Marina Malumbres,Pierfrancesco Vargiu, Ana Cayuela, Isabel Peset,Katelyn E. Connelly,
biorxiv(2024)
Elsevier eBookspp.937-966, (2024)
Cited51Views0Bibtex
51
0
Irene Felipe, Jaime Martínez-de-Villarreal,Khushbu Patel,Jorge Martínez-Torrecuadrada,Liron D. Grossmann,Giovanna Roncador, Mariona Cubells,Alvin Farrell,Nathan Kendsersky, Sergio Sabroso-Lasa, Lucía Sancho-Temiño, Kyabeth Torres,
bioRxiv the preprint server for biology (2024)
Pilar Bustamante-Madrid,Antonio Barbachano, David Albandea-Rodriguez, Javier Rodriguez-Cobos,Nuria Rodriguez-Salas,Isabel Prieto,Aurora Burgos, Jaime Martinez de Villarreal,Francisco X. Real,Jose Manuel Gonzalez-Sancho,Maria Jesus Larriba,Miguel Lafarga,
crossref(2023)
Load More
Author Statistics
#Papers: 583
#Citation: 29943
H-Index: 93
G-Index: 155
Sociability: 8
Diversity: 1
Activity: 3
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn